Biopharmaceutical services provider expands to European market - - Chromatography Online
Biopharmaceutical services provider expands to European market
Aug 17, 2009
LCGC Europe eNews

Millipore has acquired European-based services provider BioAnaLab, extending the company's biopharmaceutical services business into Europe.

"Our acquisition of BioAnaLab will allow us to build on our reputation as a trusted outsource partner in North America by establishing a presence in the fast-growing European biotech market," said Jonathan DiVincenzo, president of the company’s bioscience division, in a statement. "BioAnaLab will add cGMP support testing capabilities to our portfolio, a solid customer base and a team of services professionals with expertise in emerging scientific disciplines."

BioAnaLab current offerings include assay transfer/development, validation and sample analysis and vaccine services. Millipore's experience in biomarker analytical services is expected to strengthen BioAnaLab's current offerings in that area.

More information in Millpore can be found at www.millipore.com
and on BioAnaLab at www.bioanalab.com

ADVERTISEMENT

Rate this page
Your original vote has been tallied and is included in the ratings results.
View our top pages
 Average rating for this page is: 2
post a comment
Please complete the form below to post your comment.
Bold = Required
Email Address Your email address will NOT be published.
Display Name appears with your comment
City
State
Country
Remember me: YesNo
Comment read our privacy policy
Note: does not support HTML
All Comments submitted are subject to review, and may be delayed before posting. Comments will be posted at the discretion of the editor.
LCGC E-mail Newsletters
Global E-newsletters subscribe here:




 
Survey
Do you use countercurrent chromatography?
Yes, frequently
Yes, sometimes
No, never
Yes, frequently
74%
Yes, sometimes
6%
No, never
21%
View Results
Source: LCGC Europe eNews, 8/17/2009
Click here